Analyst Price Target is GBX 190
▲ +45.59% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for ForViva in the last 3 months. The average price target is GBX 190, with a high forecast of GBX 190 and a low forecast of GBX 190. The average price target represents a 45.59% upside from the last price of GBX 130.50.
Current Consensus is
Moderate Buy
The current consensus among 2 investment analysts is to moderate buy stock in ForViva. This rating has held steady since February 2026, when it changed from a Buy consensus rating.
ForViva
Fevara plc is an international, pure-play specialist agriculture manufacturer and provider of research-proven, value-added livestock supplements.
Fevara's mission is to drive sustainable global food security through enhancements to pasture grazing productivity, enabled by research-based products that optimise livestock performance and profitability for farmers. The Group produces nutritional animal supplements including feed licks, blocks, bagged minerals, and boluses for cattle, sheep, goats and horses. Its globally recognised brands include SmartLic, Crystalyx and Horslyx.
Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing sites in the UK, US and Brazil with three operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.
The Company has been listed on the London Stock Exchange since 1972. Fevara plc's ticker is "FVA".
For more information, visit: https://www.fevara.com/
Read More
